您的购物车当前为空
TT-012 具有抗肿瘤活性,选择性结合动态 MITF,并破坏后者的二聚体形成和 DNA 结合。TT-012 对 B16F10 黑色素瘤细胞中 MITF 的转录有抑制作用。TT-012 在动物模型中对 MITF黑色素瘤细胞的生长和肿瘤生长转移有抑制作用。TT-012 对肝脏和免疫细胞具有较少的细胞毒性。


为众多的药物研发团队赋能,
让新药发现更简单!
TT-012 具有抗肿瘤活性,选择性结合动态 MITF,并破坏后者的二聚体形成和 DNA 结合。TT-012 对 B16F10 黑色素瘤细胞中 MITF 的转录有抑制作用。TT-012 在动物模型中对 MITF黑色素瘤细胞的生长和肿瘤生长转移有抑制作用。TT-012 对肝脏和免疫细胞具有较少的细胞毒性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 378 | In Stock | |
| 5 mg | ¥ 892 | In Stock | |
| 10 mg | ¥ 1,490 | In Stock | |
| 25 mg | ¥ 2,980 | In Stock | |
| 50 mg | ¥ 4,890 | In Stock | |
| 100 mg | ¥ 6,780 | In Stock | |
| 200 mg | ¥ 9,130 | In Stock |
| 产品描述 | TT-012 has anti-tumor activity, selectively binds dynamic MITF and disrupts the dimer formation and DNA binding of the latter. TT-012 can inhibit the transcription of MITF in B16F10 melanoma cells. TT-012 inhibited the growth and metastasis of MITF melanoma cells in animal models. TT-012 is less cytotoxic to liver and immune cells. |
| 分子量 | 349.34 |
| 分子式 | C19H15N3O4 |
| CAS No. | 1164471-33-3 |
| Smiles | N(C(/C=C/C1=CC=CO1)=O)C=2N=C(NC(/C=C/C3=CC=CO3)=O)C=CC2 |
| 密度 | 1.385 g/cm3 (Predicted) |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 100 mg/mL (286.25 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (9.45 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容